Green Light Therapy to Treat Migraine

Created on 11/09/2026 – Quick Reference based on Evidence Review created using AI4L + evidence-mcp / Opus 5.5 – Audit

Green light therapy, a drug-free practice of sitting one to two hours in a dark room lit only by green light, is used daily to prevent migraine or during attacks to ease them. Small studies reported fewer, milder headaches, but reviewers rate certainty very low and much evidence comes from researchers with a financial stake. Harms appear minor at low brightness; it is a plausible, unproven add-on to existing treatment. (Full Review)

Protocol

Preventive protocol (Mohab Ibrahim, University of Arizona)
1–2 hours daily for 10 weeks
525 ± 10 nm green LED strip at 4–100 lux in a dark room
Acute protocol (Rami Burstein, Harvard, Allay Lamp)
2 hours during an attack
520 ± 10 nm lamp at 5–10 cd/m², all other lights off
Short daily protocol (Riphah International University)
1 hour a day, 5 days a week, for 4 weeks
525 ± 10 nm lamp alongside prescribed medication
Time to effect
Fewer monthly headache days
10 weeks
Natural point to judge whether headache days have fallen by half
Lower headache pain intensity
By 2 weeks
Pakistani trial; pain also fell with sham stimulation
Acute relief when used during attacks
2-hour session
Per attack; unconfirmed by controlled testing

Benefits

Contraindications
  • People whose headache worsens under green light during attacks
  • People within 5 days after verteporfin injection
  • People within at least 30 days after porfimer injection (up to 90 days in some patients)
  • People with photosensitive epilepsy using flickering or color-cycling lamps
  • People with a new, sudden or changing headache not yet evaluated
Key Interactions
Theoretical (inferred from mechanism)
  • St. John's wort
  • Migraine preventive drugs (propranolol, erenumab)
  • Acute pain relievers (ibuprofen, sumatriptan)
  • Melatonin
  • Migraine supplements (magnesium, riboflavin)
  • Tinted lenses (FL-41 rose tint, blue-blocking glasses)
  • Transcranial direct current stimulation (tDCS)

Risk & Side Effects

  • High:
  • Medium: Headache worsening or triggering
  • Low: Evening body-clock disruption
  • Speculative: Delayed effective treatment, flicker from low-cost light strips, retinal light injury

Monitoring

Marker Target Why
Monthly headache days No established target; track change from own 4-week baseline Main benefit
Attack pain intensity (NPS, 0–10) No established target; track average attack score against baseline Expected to change
HIT-6 score No established target; track change from baseline Disability
Acute medication days per month No established target; track against baseline Safety check: medication-overuse headache
Light at the eye (lux) No established target; record the reading and keep it stable Safety check: brighter light worsens headache in some patients

Cadence: 4-week diary before starting; daily diary with reviews at 2, 4 and 10 weeks, then every 3 months; HIT-6 monthly; lux reading repeated after any change in lamp position or device

Qualitative Assessment

  • Sleep quality: ease of falling and staying asleep after sessions
  • Calm during attacks: anxiety and irritability with the lamp on
  • Light sensitivity: tolerance of ordinary room and screen light
  • Daily function: ability to work and complete planned activities
  • Adherence: sessions completed per week and their length